[Thrombolytic therapy. II].
D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy*; D004342:Drug Hypersensitivity; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy*
D005343:Fibrinolytic Agents; D013300:Streptokinase
Leczenie trombolityczne. II.